BackBriaCell Therapeutics Overview

BriaCell Therapeutics Selling, General & Admin

Selling, General & Admin expenses for BCTX.

Quarterly SG&A Expenses

$1.65M
↑ 8.96% YoY

As of Apr 30, 2026

Annual SG&A Expenses (TTM)

$6.22M
↑ 6.19% YoY

Trailing 12 months ending Apr 30, 2026

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin